COVID-19 Update | December 18, 2020

COVID-19 Vaccine Update

Great news! CVS notified us today that they will tentatively be onsite at the NeuroCare Campus on January 7th to administer the COVID-19 vaccine to our NCC clients and staff. The vaccination is a two-dose process and the second dose will tentatively be administered on January 28th.  We also wanted to share the news that this evening the FDA approved the Moderna COVID-19 vaccine which will add millions of doses to the U.S. supply.

Next Steps

On Monday, December 21st, members of the COVID-19 Watch Team will begin calling NCC family members and guardians to discuss the process for giving consent for NCC clients to be vaccinated.  An email was sent this evening to current NeuroCare Campus clients, families, and friends with important information about the consent process that requires urgent action.  Please contact your Special Tree Case Manager if you did not receive the email. 

Special Tree supports the CDC and Michigan Department of Health and Human Services in strongly recommending to get vaccinated.  Research shows that the benefits of the vaccine far outweigh the risks for most people.  You can find answers to commonly asked questions about the COVID-19 vaccine at Michigan.gov. 

Here are the latest updates:

• At this time, we have no active cases of COVID-19 for clients in our system.
• We continue to track our client and staff pending and confirmed cases on the COVID-19 page of our website.
• Mandatory bi-weekly testing continued this week for all NeuroCare Campus clients and staff on Tuesdays and Fridays from 12pm to 5pm.  During the holidays, we will be testing clients and staff once a week. 
• Post-exposure precautions are in place at our Royal Oak Residence including an in-home quarantine, full PPE usage, and suspension of all activities and therapy services until COVID-19 test results are confirmed.
• This week, a staff member at our Heavlin Residence at the NeuroCare Campus is on a 14-day quarantine as a precaution following a post-exposure from a family member who tested positive.
• Visitor restrictions are in place until further notice. We are aggressively managing our supply of Personal Protective Equipment (PPE) and are following best practices for disinfecting and cleaning our facilities. We continue to appropriately secure supplies in anticipation of routine needs such as the current flu season